Succeeding with Combination Therapy for DME
By: John D. Pitcher, III, MD; Jean-Pierre Hubschman, MD
Treatment options must be tailored to the individual patient
Immunotherapy for Uveal Melanoma: Obstacles and Opportunities
By: Jerry Y. Niederkorn, PhD; Yuguang He, MD
Immune privilege in the eye presents interesting and unique challenges
The Role of Predictors of Success in Managing Vitreomacular Adhesions
By: Jay Chhablani, MD; William R. Freeman, MD
SD-OCT represents a major advance in understanding VMA
Anatomic Outcomes in Clinical Trials for Retina
By: Andrew E. Mathis, PhD, Medical Editor
OCT has changed retina practice, but how are clinical trials being affected?
Assessing Antibiotic Use With Intravitreal Injections
By: Samantha Stahl, Assistant Editor
Are they a line of defense against infection, or do they increase the risk of resistance?
Considering the Treatment Options for Choroidal Hemangioma
By: Breno R. Lima, MD; Arun D. Singh, MD
The two types of this benign lesion dictate different treatment modalities
Growth Factor Therapy for Retinal Neuroprotection
By: Reema Syed, MD; Jacque L. Duncan, MD
CNTF's potential role in future retinal therapies
Microincision Vitrectomy Surgery For Diabetic Retinopathy
By: Taku Wakabayashi, MD; Yusuke Oshima, MD, PhD
Current strategies and future perspectives
Special Section Series Sponsored By Alcon
By: Pravin U. Dugel, MD
New Technique for Tissue Separation
Upfront: From the Editor-in-Chief
By: Jason S. Slakter, M.D.
Let’s fight negativity
Subspecialty News
HHS study finds Avastin cost advantage; IMT improves quality of life; and more
Guest Editorial
By: Pravin U. Dugel, MD
The public's distorted views on CATT data
Controversies in Care
By: Michael Colucciello, MD
Does “tomographically significant macular edema” exist?
Coding Q&A
By: Riva Lee Asbell
Resolving the Coding Dilemmas Related to Remote Imaging
Focus On
By: Samantha Stahl, Assistant Editor
577-nm wavelength system delivers safety